WEST PHARM.SVCS DL-,25/ US9553061055 /
28/08/2024 21:42:53 | Chg. -3.700 | Volume | Bid22:00:01 | Ask22:00:01 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
265.400EUR | -1.37% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 19.3 bill.EUR | - | - |
Assets
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 593.6000 | 669 | 711.7000 | 705.8000 | 721 | ||||||
Intangible Assets | 52 | 50.6000 | 48.3000 | 42 | 37.6000 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | - | - | 1,011.6000 | 1,021.4000 | ||||||
Inventories | 151.8000 | 162.2000 | 176.9000 | 181.5000 | 181.1000 | ||||||
Accounts Receivable | 147.2000 | 175 | 185.7000 | 179 | 181.4000 | ||||||
Cash and Cash Equivalents | 91.8000 | 161.9000 | 230 | 255.3000 | 274.6000 | ||||||
Current Assets | 472 | 557.3000 | 650.7000 | 659.3000 | 673.7000 | ||||||
Total Assets | 1,399.1000 | 1,564 | 1,671.6000 | 1,670.9000 | 1,695.1000 |
Liabilities
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 89.8000 | 102.9000 | 108 | 103.1000 | 119.8000 | ||||||
Long-term debt | - | - | - | 309.5000 | 228.9000 | ||||||
Liabilities to Banks | 50.1000 | 32.7000 | 2.2000 | 27.2000 | 69.3000 | ||||||
Provisions | 31.1000 | 28.6000 | 26.7000 | 30.6000 | 25.2000 | ||||||
Liabilities | 744.2000 | 835.1000 | 765.2000 | 714 | 671.2000 | ||||||
Share Capital | 17.2000 | 17.2000 | 17.6000 | 17.8000 | 18.1000 | ||||||
Total Equity | 654.9000 | 728.9000 | 906.4000 | 956.9000 | 1,023.9000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 1,399.1000 | 1,564 | 1,671.6000 | 1,670.9000 | 1,695.1000 |
Income Statement
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1,192.3000 | 1,266.4000 | 1,368.4000 | 1,368.4000 | 1,399.8000 | ||||||
Depreciation (total) | - | - | - | 81 | 86.1000 | ||||||
Operating Result | 109.6000 | 135.1000 | 162.4000 | 162.4000 | 128.6000 | ||||||
Interest Income | -16.9000 | -14.9000 | -15.1000 | 17 | 14.1000 | ||||||
Income Before Taxes | 92.7000 | 108.6000 | 147.1000 | 147.1000 | 116.1000 | ||||||
Income Taxes | 23.5000 | 32.7000 | 40.2000 | 40.2000 | 26.3000 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 75.5000 | 80.7000 | 112.3000 | 112.3000 | 95.6000 |
Per Share
Cash Flow
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 130.7000 | 187.4000 | 220.5000 | 220.5000 | 212.4000 | ||||||
Cash Flow from Investing Activities | -120.5000 | -116 | -149.9000 | -149.9000 | -129.5000 | ||||||
Cash Flow from Financing | -24.7000 | -3.4000 | -5.1000 | -5.1000 | -41.5000 | ||||||
Decrease / Increase in Cash | -18.4000 | 70.1000 | 68.1000 | 68.1000 | 19.3000 | ||||||
Employees | 6,300 | 6,700 | 6,900 | 7,000 | 7,100 |